AtriCure, Inc. (ATRC) Financials
ATRC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 591.6 million | 135.3 million |
2023-12-31 | 613.9 million | 147.8 million |
2023-09-30 | 600.3 million | 137.4 million |
2023-06-30 | 594.2 million | 131.7 million |
ATRC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -23.8 million | 9.3 million |
2023-12-31 | 1.2 million | 9.3 million |
2023-09-30 | -2.1 million | 8.7 million |
2023-06-30 | -30.1 million | 9.0 million |
ATRC Net Income
No data available :(
ATRC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | - | - | 13.5 million |
2023-12-31 | 137.3 million | - | 11.4 million |
2023-09-30 | 133.0 million | - | 11.5 million |
2023-06-30 | 127.0 million | 47.0 million | 12.1 million |
ATRC Shares Outstanding
ATRC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 2.8 million | 19.8 million | 72.3 million | - |
2023-12-31 | 2.8 million | 20.8 million | 67.7 million | - |
2023-09-30 | 3.6 million | 20.4 million | 61.6 million | - |
2023-06-30 | 33.1 million | 17.4 million | 63.8 million | - |
ATRC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 108.9 million | 27.6 million |
2023-12-31 | 106.5 million | 27.5 million |
2023-09-30 | 98.3 million | 24.4 million |
2023-06-30 | 100.9 million | 23.8 million |
ATRC
Price: $22.10
52 week price:
Earnings Per Share: -0.66 USD
P/E Ratio: -63.35
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 186700
Ebitda: -4.4 millionMarket Capitalization: 1.1 billion